🔵 RESEARCH
Trial tests POCUS against X-ray for elbow fracture diagnosis
A clinical trial is evaluating point-of-care ultrasound versus X-ray for diagnosing elbow fractures in emergency settings.
If POCUS matches X-ray, emergency workflows and paediatric radiation exposure could shift. But without a CT reference standard, both modalities may share the same blind spots — watch for sensitivity data against true gold standards.
🔵 RESEARCH
Deep learning echo trial targets LV/RV and valvular assessment
A clinical trial is deploying AI-Echo algorithms to assist clinicians in interpreting LV/RV function, valvular disease severity, and disease progression risk.
Cardiac ultrasound AI remains fragmented with no technical standard, preserving incumbents' moats at GE and Philips. Without disclosed endpoints or power calculations, the trial's weight for clinical validation versus feasibility testing is unclear.
🔵 RESEARCH
Multicenter study validates real-time AI for liver lesion detection on ultrasound
NPJ Digital Medicine published multicenter validation of a deep learning system detecting focal liver lesions in real time on ultrasound video.
Real-time liver AI at validation stage is prime acquisition bait for ultrasound OEMs seeking portfolio differentiation in a multi-billion-dollar screening market. But performance across varying equipment, operators, and community settings remains the open question.
NPJ Digital Medicine · 2026-04-16
Read more → (paywall)
🔴 REGULATORY
FDA clears Philips Verida spectral CT
Philips received FDA clearance for its Verida spectral CT system, expanding its US advanced CT portfolio.
Philips sharpens the three-way premium CT battle with GE's Revolution and Siemens' SOMATOM, where spectral margins run 30–40% above conventional CT. Imaging directors still need to justify the protocol and training overhead to realise dual-energy benefits beyond cardiac and oncology.
⚪ INDUSTRY
Major AI merger closes as SimonMed partners and new radiology CPT code lands
Radiology Business reported a finalised major imaging AI merger, a SimonMed AI partnership, and approval of a new CPT code for a radiology product.
Following this week's Hologic, GE HealthCare, and Sectra deals, the signal is unambiguous: capital favours AI assets with reimbursement paths. Imaging leaders should discount the M&A noise and track named health-system deployments with workflow impact.
⚪ INDUSTRY
ACR expands toolkit for evaluating imaging AI
The American College of Radiology expanded its resources to help practices evaluate imaging AI solutions before procurement.
Standardised evaluation could become a procurement gatekeeper, favouring vendors with the resources to meet ACR criteria and potentially creating a two-tier market. Practices gain due diligence rigour, but workflow integration and ROI battles remain unsolved.
🩺 EDITOR’S TAKE — FOR CLINICIANS
Watch the validation gap: echo and liver ultrasound AI trials are proliferating, but most lack true gold-standard comparators. Demand sensitivity data against CT or MRI — not just concordance with legacy modalities — before changing practice.
📊 EDITOR’S TAKE — FOR INVESTORS
CPT codes, FDA clearances, and consolidation are converging. The Philips spectral CT nod and this week's AI merger signal capital is flowing to assets with reimbursement pathways, not pure technology bets. Validation-stage ultrasound AI is next acquisition bait.
🏭 EDITOR’S TAKE — FOR INDUSTRY
ACR's expanded AI evaluation toolkit is the gatekeeping infrastructure OEMs have been waiting for — and fearing. Expect validated-vendor tiers to harden procurement, while Philips' spectral entry intensifies the three-way premium CT fight with GE and Siemens.